Peripheral donor leukocytes prolong survival of rat renal allografts

Kidney International

Volumn 56, Issue 3, 1999, Pages 1101-1112

  Noris, Marina ^a,b   Azzollini, Nadia ^a   Mister, Marilena ^a   Pezzotta, Angela ^a   Piccinini, Giampiero ^a   Casiraghi, Federica ^a   Cugini, Daniela ^a   Perico, Norberto ^a   Orisio, Silvia ^a   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Cyclosporine; Microchimerism; Mononuclear leukocyte; Rat MHC class II gene; Transplantation

Indexed keywords

CYCLOSPORIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; INFUSION; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROCHIMERISM; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032824439     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00632.x     Document Type: Article

References (46)

1. 1. Charlton B, Auchincloss H, Wood M, Sahyoun A, Codish S, Brown R: Mechanisms of transplantation tolerance. Annu Rev Immunol 12:707-734, 1994
2. 2. Brennan D, Mohanakumar T, Flye W: Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: A review of efficacy and mechanisms. Am J Kidney Dis 26:701-715, 1995
3. 3. Barber H, Mankin J, Laskow D, Deierhoi M, Julian B, Curtis J, Diethelm A: Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 51:70-75, 1991
4. 4. Fontes P, Rao A, Demetris A, Zeevi A, Trucco M, Carroll P, Rybka W, Rudert W, Ricordi C, Dodson F, Shapiro R, Tzakis A, Todo S, Abu-Elmagd K, Jordan M, Fung J, Starzl T: Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 344:151-155, 1994
5. 5. Ricordi C, Karatzas T, Nery J, Webb M, Selvaggi G, Fernandez H, Bean J, Esquenazi V, Joshua M, Tzakis A: High-dose donor bone marrow infusions to enhance allograft survival: The effect of timing. Transplantation 63:7-11, 1997
6. 6. Starzl T, Demetris A, Trucco M: Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance. Hepatology 17:1127-1152, 1993
7. 7. Starzl T, Demetris A, Murase N, Ildstad S, Ricordi C, Trucco M: Cell migration, chimerism, and graft acceptance. Lancet 339:1579-1582, 1992
8. 8. Rao A, Thomson A, Shapiro R, Starzl T: Chimerism after whole organ transplantation: Its relationship to graft rejection and tolerance induction. Curr Opin Nephrol Hypertens 3:589-595, 1994
9. 9. Starzl T, Zinkernagel R: Antigen localization and migration in immunily and tolerance. N Engl J Med 339:1905-1913, 1998
10. 10. Thomson AW, Lu L, Subbotin V, Starzl T: Propagation of dendritic cell progenitors from mouse liver and their in vivo migration to T-dependent areas of allogeneic lymphoid tissue. Transplant Proc 26:3484-3486, 1994
11. 11. Thomson AW, Lu L, Subbotin VM, Li Y, Qian S, Rao AS, Fung JJ, Starzl TE: In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients: Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation 59:544-551, 1995
12. 12. Steinman RM, Inaba K, Austyn JM: Donor-derived chimerism in recipients of organ transplants. Hepatology 17:1153-1156, 1993
13. 13. Terakura M, Murase N, Demetris A, Ye Q, Thomson A, Starzl T: Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. Transplantation 66:350-357, 1998
14. 14. Ildstad ST, Sachs DH: Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168-170, 1984
15. 15. Tomita Y, Khan A, Sykes M: Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 153:1087-1098, 1994
16. 16. De Vries-Van Der Zwan A, Besseling A, De Waal L, Boog C: Specific tolerance induction and transplantation: A single-day protocol. Blood 89:2596-2601, 1997
17. 17. Sun J, Sheil A, Wang C, Wang L, Rokahr K, Sharland A, Jung S-E, Li L, Mccaughan G, Bishop G: Tolerance to rat liver allografts. IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 62:1725-1730, 1996
18. 18. Murase N, Starl T, Tanabe M, Fujisaki S, Miyazawa H, Ye Q, Delaney C, Fung J, Demetris A: Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cells and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 60:158-171, 1995
19. 19. Perico N, Imberti O, Bontempelli M, Remuzzi G: Toward novel antirejection strategies: In vivo immunosuppressive properties of CTLA4Ig. Kidney Int 47:241-246, 1995
20. 20. She J, Boehme S, Wang T, Bonhomme F, Wakeland E: Amplification of major histocompatibility complex class II gene diversity by intraexonic recombination. Proc Natl Acad Sci USA 88:453-457, 1991
21. 21. Starzl T, Demetris A, Murase N, Thomson A, Trucco M, Ricordi C: Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation. Immunol Today 14:326-332, 1993
22. 22. Lasalle J, Hafler M: T cell anergy. FASEB J 8:601-608, 1994
23. 23. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 172:603-606, 1953
24. 24. Ehl S, Aichele P, Ramseier H, Barchet W, Hombach J, Pircher H, Hengartner H, Zinkernagel, R: Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nature Med 4:1015-1019, 1998
25. 25. Starzl T, Demetris A, Murase N, Trucco M, Thomson A, Rao A: The lost chord: Microchimerism and allograft survival. Immunol Today 17:577-584, 1996
26. 26. Yokoi Y, Hirasawa S, Iwaya M, Okuyama S, Nakamura S, Baba S, Miyamoto M, Tsujimoto G, Amemiya H, Kimura H: Microchimerism and liver graft acceptance. Transplant Proc 27:1555-1557, 1995
27. 27. Suberbielle C, Caillat-Zucman S, Legendre C, Bodemer C, Noel LH, Kreis H, Bach JF: Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet 343:1468-1469, 1994
28. 28. Schlitt HJ, Hundrieser J, Hisanaga M, Uthoff K, Karck M, Wahlers T, Wonigett K, Pichlmayr R: Patterns of donor-type microchimerism after heart transplantation. Lancet 343:1469-1471, 1994
29. 29. Reisner Y, Martelli M: Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 16:437-440, 1995
30. 30. Salvatierra O Jr, Vincenti F, Amend W, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D, Stoney RJ, Feduska NJ: Deliberate donor-specific blood transfusions prior to living related renal transplantation: A new approach. Ann Surg 192:543-552, 1980
31. 31. Salvatierra OJ, Melter J, Potter D, Garavoy M, Vincenti F, Amend W, Husing R, Hopper S, Feduska N: A 7-year experience with donor specific blood transfusions. Transplantation 40:654-659, 1985
32. 32. Colombe B, Lou C, Salvatierra OJ, Garovoy M: Two patterns of sensitization demonstrated by recipients of donor-specific transfusion. Limitations to control by Imuran. Transplantation 44:509-515, 1987
33. 33. Miyauchi T, Ishikawa M, Tashiro S, Hisaeda H, Nagasawa H, Himeno K: Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. Transplantation 65:27-32, 1998
34. 34. Morita H, Sugiura K, Inaba M, Jin T, Ishikawa J, Lian Z, Adachi Y, Sogo S, Yamanishi K, Taki H, Adachi M, Noumi T, Kamiyama Y, Good R, Ikehara S: A strategy for organ allografts without using immunosuppressants or irradiation. Proc Natl Acad Sci USA 95:6947-6952, 1998
35. 35. Calne R: New strategies in tolerance. Med Sci Res 19:230-231, 1991
36. 36. Calne R, Davies H: Organ graft tolerance: The liver effect. Lancet 343:67-68, 1994
37. 37. Sumimoto R, Kamada N: Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 50:678-682, 1990
38. 38. Spencer SC, Fabre JW: Bulk purification of a naturally occurring soluble form of RT1-A class I major histocompatibility complex antigens from DA rat liver, and studies of specific immunosuppression. Transplantation 44:141-148, 1987
39. 39. Priestley CA, Dalchau R, Sawyer GJ, Fabre JW: A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses. Transplantation 48:1031-1038, 1989
40. 40. Thomas J, Verbanac K, Thomas F: The veto mechanism in transplant tolerance. Transplant Rev 5:209-229, 1991
41. 41. Thomas J, Carver F, Kasten-Jolly J, Haisch C, Rebellato L, Gross U, Vore S, Thomas F: Further studies of veto activity in Rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 57:101-115, 1994
42. 42. Khan A, Tomita Y, Sykes M: Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Transplantation 62:380-387, 1996
43. 43. Nikolic B, Lei H, Pearson D, Sergio J, Swenson K, Sykes M: Role of intrathymic rat class II cells in maintaining deletional tolerance in xenogeneic rat mouse bone marrow chimeras. Transplantation 65:1216-1224, 1998
44. 44. Remuzzi G, Perico N, Carpenter C, Sayegh M: The thymic way to transplantation tolerance. J Am Soc Nephrol 5:1639-1646, 1995
45. 45. Markmann J, Odorico J, Bassiri I, Desai N, Kim J, Barker C: Deletion of donor reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells. Transplantation 55:871-877, 1993
46. 46. Jones N, Fluck N, Roelen D, Mellor A, Morris P, Wood K: Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration. Eur J Immunol 27:1591-1600, 1997